Hamza Celik is the Director of Hematology-Oncology Drug Discovery at Incyte, where he leads multi-disciplinary teams on small molecule drug discovery programs from initial identification to IND. His expertise is rooted in his academic research at Washington University and a Ph. D. from CNRS, complemented by a recent PocketMBA.
Outside of his direct research, Hamza is a supportive leader who actively mentors scientists and champions rising talent in the field. He shows a keen interest in the intersection of science and business, following publications like the Harvard Business Review and encouraging recruitment for his growing teams.
Unique fact: Hamzas past research included developing strategies to use CRISPR technology as a "finely-honed molecular scalpel" to edit the epigenome.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Explore more public profiles from related professionals.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.